Endpoints and objectives
VIRUS
The primary endpoint of the CARVIN study was the assessment of virus load kinetics of SARS-CoV-2 by determining the presence and amount of viral carriage via PCR. Applied treatment regimens aimed to explore differences regarding viral carriage upon treatment with azelastine compared to placebo. Secondary endpoints included the assessment of symptoms, patient status (using a 11-category ordinal score as proposed by the WHO